Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry
暂无分享,去创建一个
R. Gómez-Huelgas | M. Rubio-Rivas | L. Pérez-Belmonte | J. Bascuñana | M. Méndez-Bailón | R. Quirós-López | María Luisa Taboada Martínez | F. Roque-Rojas | E. Montero Hernández | J. Azaña Gómez
[1] M. Jaguszewski,et al. Pharmacotherapy of atrial fibrillation in COVID-19 patients , 2021, Cardiology journal.
[2] C. Macaya,et al. [Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry]. , 2021, Revista espanola de cardiologia.
[3] Alfarooq M. Alshaikhli,et al. New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-19 Patient , 2021, Cureus.
[4] G. Lip,et al. Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19 , 2020, Journal of arrhythmia.
[5] J. Z. Zamorano Gómez,et al. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. , 2020, Cardiology journal.
[6] M. Méndez-Bailon,et al. Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.
[7] Utkarsh Kohli,et al. Fulminant myocarditis and atrial fibrillation in child with acute COVID-19 , 2020, Journal of Electrocardiology.
[8] S. Yusuf,et al. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation , 2020, European heart journal.
[9] D. Dobrev,et al. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications , 2020, IJC Heart & Vasculature.
[10] Benjamin S. Glicksberg,et al. Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 , 2020, Journal of the American College of Cardiology.
[11] J. Ramos-Rincón,et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry☆ , 2020, Revista Clínica Española (English Edition).
[12] J. Ramos-Rincón,et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry , 2020, Revista Clínica Española (English Edition).
[13] W. Ullah,et al. COVID-19 Presenting as Takotsubo Cardiomyopathy Complicated with Atrial Fibrillation , 2020, IJC Heart & Vasculature.
[14] F. Mahoney,et al. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.
[15] F. Chorro,et al. Prevalence of atrial fibrillation in Spain. OFRECE study results. , 2014, Revista espanola de cardiologia.
[16] J. Pérez-Villacastín,et al. Epidemiology of atrial fibrillation in Spain in the past 20 years. , 2013, Revista espanola de cardiologia.
[17] R. Franken,et al. Atrial fibrillation in the elderly , 2012, Journal of geriatric cardiology : JGC.
[18] A. Feinstein,et al. A new clinical index of growth rate in the staging of breast cancer. , 1980, The American journal of medicine.
[19] F. Félix-Redondo,et al. Prevalence of atrial fibrillation and its associated factors in Spain: An analysis of 6 population-based studies. DARIOS Study. , 2014, Revista clinica espanola.